AI TextQuick Glance (AI)Headnote
Issues: (i) whether corporate guarantee given for an associated enterprise constituted an international transaction warranting transfer pricing adjustment; (ii) whether interest disallowance on alleged diversion of borrowed funds to sister concerns was sustainable; (iii) whether weighted deduction under section 35(2AB) could be restricted by DSIR certification and whether the additional claim on gross R&D expenditure was allowable; (iv) whether product registration expenditure was capital or revenue in nature; (v) whether disallowance under section 14A could exceed exempt income and be again added while computing book profit under section 115JB; (vi) whether foreign exchange derivative loss was speculative loss or business loss; (vii) whether freebies and incentives to doctors were hit by Explanation 1 to section 37(1); (viii) whether employees' contribution to welfare funds deposited belatedly was deductible under section 36(1)(va) read with section 2(24)(x); and (ix) whether bonus payment claimed under section 43B required verification and could be allowed.
Issue (i): whether corporate guarantee given for an associated enterprise constituted an international transaction warranting transfer pricing adjustment.
Analysis: The guarantee was a continuation of an earlier arrangement and no fresh guarantee or additional cost, burden, or economic outflow was shown for the year. The earlier orders in the assessee's own case had already treated the same arrangement as not requiring benchmarking on the facts then prevailing. Judicial consistency also supported the view that a corporate guarantee, in the absence of cost or sacrifice, could not be mechanically equated with a bank guarantee for arm's length pricing.
Conclusion: The transfer pricing adjustment on corporate guarantee was not sustainable and the finding is in favour of the assessee.
Issue (ii): whether interest disallowance on alleged diversion of borrowed funds to sister concerns was sustainable.
Analysis: The advances were found to be commercially expedient and business-related, while the Assessing Officer failed to establish a direct nexus between borrowed funds and the advances. The settled principle is that once business nexus and commercial expediency are shown, the Revenue cannot substitute its own judgment for that of the businessman. A further presumption arises where sufficient interest-free funds are available.
Conclusion: The disallowance under section 36(1)(iii) was rightly deleted and the issue is in favour of the assessee.
Issue (iii): whether weighted deduction under section 35(2AB) could be restricted by DSIR certification and whether the additional claim on gross R&D expenditure was allowable.
Analysis: For the relevant year, the pre-amended statutory scheme governed the claim. Earlier binding decisions in the assessee's own case, together with jurisdictional precedent, held that once the research facility is approved and the expenditure is genuinely incurred for scientific research, deduction cannot be curtailed merely because Form 3CL reflects a different figure. The additional claim on contract research receipts was also allowed because the provision does not impose a restriction that deduction is confined only to the amount certified in Form 3CL.
Conclusion: The weighted deduction claim, including the additional claim, was allowable and the issue is in favour of the assessee.
Issue (iv): whether product registration expenditure was capital or revenue in nature.
Analysis: The expenditure was incurred to obtain foreign regulatory approvals needed to market pharmaceutical products. It was recurring, operational, and regulatory in character, and did not create any independent capital asset or proprietary right. The mere possibility of benefit extending beyond one year did not convert an otherwise business expenditure into capital expenditure.
Conclusion: The product registration expenditure was allowable as revenue expenditure and the issue is in favour of the assessee.
Issue (v): whether disallowance under section 14A could exceed exempt income and be again added while computing book profit under section 115JB.
Analysis: The disallowance under section 14A is confined to expenditure actually incurred in relation to exempt income and cannot exceed the exempt income earned. The MAT adjustment under section 115JB must be computed independently and cannot mechanically import the section 14A computation. Adding the same amount again under section 115JB would amount to impermissible duplication.
Conclusion: The restriction of the disallowance and deletion of the MAT adjustment were correct and the issue is in favour of the assessee.
Issue (vi): whether foreign exchange derivative loss was speculative loss or business loss.
Analysis: The contracts were entered into to hedge genuine foreign currency exposure arising from import-export business. Where derivative contracts are intended to mitigate business risk and are integrally connected with business operations, the resulting loss is a normal business loss and not speculative loss. The Revenue failed to show that the transactions were independent speculative ventures.
Conclusion: The foreign exchange fluctuation loss was allowable as business loss and the issue is in favour of the assessee.
Issue (vii): whether freebies and incentives to doctors were hit by Explanation 1 to section 37(1).
Analysis: Expenditure incurred in providing prohibited freebies to medical practitioners is disallowable under Explanation 1 to section 37(1). The binding law treats such spend as barred by law, and the CBDT circular was only declaratory of that position.
Conclusion: The disallowance was rightly sustained and the issue is against the assessee.
Issue (viii): whether employees' contribution to welfare funds deposited belatedly was deductible under section 36(1)(va) read with section 2(24)(x).
Analysis: Employees' contribution is governed by section 36(1)(va) and must be deposited within the due date prescribed under the relevant welfare enactment. Payment before filing the return does not cure the default. The later payment did not satisfy the statutory condition for deduction.
Conclusion: The disallowance was correctly sustained and the issue is against the assessee.
Issue (ix): whether bonus payment claimed under section 43B could be allowed without verification.
Analysis: Deduction under section 43B depends on actual payment and requires factual verification of payment within the prescribed time. Since the supporting material needed verification, the matter was restored for examination by the Assessing Officer.
Conclusion: The claim was not finally allowed or rejected and was remitted for verification.
Final Conclusion: The Revenue's appeal failed in full, while the assessee obtained relief on the major disputed additions, with one bonus-related claim sent back for verification.
Ratio Decidendi: Corporate guarantee without demonstrated cost or economic sacrifice is not automatically benchmarkable; interest cannot be disallowed where advances are commercially expedient and supported by own funds; weighted deduction under section 35(2AB) cannot be curtailed merely by DSIR quantification where genuine eligible expenditure is shown; section 14A disallowance cannot exceed exempt income nor be duplicated under MAT; genuine hedging losses are business losses; and statutory prohibitions under section 37(1) and the employee-contribution rules must be strictly enforced.
Corporate guarantee, section 14A limits and research deduction rules shaped the tax treatment of key business claims.
Corporate guarantee to an associated enterprise was treated as not warranting transfer pricing adjustment where no fresh guarantee, cost, or economic sacrifice was shown. Interest disallowance for alleged diversion of borrowed funds failed because the advances were commercially expedient and no direct nexus with borrowings was proved. Weighted deduction for scientific research was not confined to DSIR certification where eligible expenditure was genuinely incurred, while product registration costs were held revenue in nature. Section 14A disallowance could not exceed exempt income or be duplicated in book profit, hedging derivative loss was business loss, and doctor freebies and belated employees' contribution remained disallowable; bonus payment required factual verification.
Transfer pricing on corporate guarantee - Commercial expediency of interest-free advances - Weighted deduction for approved scientific research - Product registration expenditure - Disallowance under section 14A - MAT adjustment for exempt-income expenditure - Hedging loss and speculative transaction - Freebies to medical practitioners - Employees' contribution to welfare funds - Deduction on actual payment basis Transfer pricing on corporate guarantee - International transaction - HELD THAT: - The Tribunal upheld deletion of the adjustment because the factual finding remained unrebutted that no fresh guarantee was issued during the year and the assessee had not incurred any additional cost, burden or economic outflow in continuing the arrangement. Following the orders in the assessee's own earlier years [2017 (9) TMI 727 - ITAT AHMEDABAD] for Assessment Year 2011-12, it held that in such circumstances no benchmarking exercise or arm's length guarantee commission could be imposed. [Paras 19, 20] The deletion of the corporate guarantee adjustment was affirmed and the Revenue's grounds on this issue were dismissed. Interest on borrowed capital - Commercial expediency - Disallowance of interest on the footing of diversion of borrowed funds to sister concerns - HELD THAT: - The Tribunal accepted the finding that the advances were commercially expedient and connected with business operations, and that the Assessing Officer had not established any direct nexus between borrowed funds and the advances. Applying the settled principle that business expediency is to be judged from the standpoint of the businessman, and following the consistent view in the assessee's own case, it held that the interest disallowance could not survive. [Paras 23, 26, 27] The deletion of the disallowance under section 36(1)(iii) was upheld. Weighted deduction for scientific research - DSIR approval - whether weighted deduction under section 35(2AB) could be restricted by DSIR certification? - HELD THAT: - The Tribunal held that the controversy was governed by the pre-amendment legal position applicable to Assessment Year 2013-14. Under that regime, once the in-house facility stood approved and the expenditure was genuinely incurred for scientific research purposes, deduction could not be curtailed only because the quantum shown in Form 3CL differed from the assessee's claim. The later amendments enhancing the role of DSIR in quantification were treated as prospective and inapplicable to the year in appeal. [Paras 36, 37, 38, 39, 40] The Revenue's challenge to deletion of the disallowance u/s 35(2AB) failed. Nature of expenditure - Product registration expenditure - Expenditure incurred for registration of pharmaceutical products in foreign jurisdictions - HELD THAT: - The Tribunal held that such registration and approval expenses are a recurring and integral incident of pharmaceutical business and do not create any proprietary or transferable capital asset. The fact that approvals may remain effective beyond one year was held insufficient to convert the outlay into capital expenditure, since the expenditure merely facilitates carrying on business in export markets. [Paras 49, 50, 51, 52] The deletion of the disallowance of product registration expenditure was affirmed. Disallowance u/s 14A - Exempt income ceiling - HELD THAT: - The Tribunal reiterated that section 14A is aimed at disallowing only actual expenditure having proximate nexus with exempt income and cannot be used to create an artificial disallowance exceeding such income. Rule 8D was treated as only a computation mechanism that cannot enlarge the substantive scope of the disallowance. In the absence of any demonstrated infirmity in the appellate findings, the restriction made by the appellate authority was sustained. [Paras 60, 61, 62, 63, 64] The Revenue's ground against restriction of disallowance under section 14A was dismissed. MAT adjustment for exempt-income expenditure - Independent computation of book profit - HELD THAT: - The Tribunal held that computation under section 115JB operates independently and the Rule 8D mechanism cannot be imported into clause (f) of Explanation 1. Only actual expenditure debited to the profit and loss account and directly relatable to exempt income can be considered for adjustment under the MAT provisions. It also noted that once the disallowance under the normal provisions stood restricted, a corresponding MAT addition on the same basis would amount to impermissible duplication. [Paras 71, 72, 73, 74, 75] Deletion of the addition made u/s 115JB in relation to section 14A disallowance was upheld. Foreign exchange derivative loss - Hedging transactions - Speculative loss - Foreign exchange derivative loss arising from contracts entered into for business exposure allowable as business loss or speculative loss - HELD THAT: - The Tribunal found that the contracts were entered into with banks to safeguard the assessee's import-export exposure and no material had been brought by the Revenue to show that they were independent speculative ventures. It held that absence of actual delivery is not decisive where the transactions are demonstrably linked to underlying business exposure and undertaken for risk mitigation. On that basis, the loss retained the character of normal business loss. [Paras 82, 83, 84, 85, 86] The deletion of the disallowance of foreign exchange fluctuation loss was sustained. Freebies to medical practitioners - Explanation 1 to business expenditure deduction - Expenditure on freebies, gifts, incentives and similar benefits to doctors and medical practitioners - HELD THAT: - The Tribunal held that the matter stood concluded by binding Supreme Court authority that expenditure incurred in providing freebies to medical practitioners is prohibited in law and therefore falls within the mischief of Explanation 1 to section 37(1). It rejected the plea that the expenditure should still be allowed as business promotion expenditure. [Paras 93, 94, 95, 97, 98] The disallowance of expenditure on freebies and incentives to doctors was upheld. Employees' contribution to welfare funds - Deposit beyond statutory due date though paid before the due date of filing the return - HELD THAT: - The Tribunal applied the Supreme Court [2022 (10) TMI 617 - SUPREME COURT (LB)] ruling that employees' contribution, being deemed income, is deductible only upon fulfilment of the specific condition in section 36(1)(va), namely deposit within the due date under the relevant welfare statute. It rejected the contention that the principle should be confined to provident fund or ESI and held that the statutory distinction between employer's contribution and employees' contribution governed the present welfare fund contributions as well. [Paras 109, 110, 111, 112, 113] The disallowance under section 36(1)(va) read with section 2(24)(x) was affirmed. Additional weighted deduction claim - Gross scientific research expenditure - HELD THAT: - The Tribunal found that once the scientific research expenditure was accepted as genuine and eligible, deduction under section 35(2AB) had to be allowed on the gross eligible expenditure and could not be denied merely because contract research income had been reduced in the original computation. Since the Revenue had not disputed the genuineness or purpose of the expenditure, the denial of the additional claim was held to be unsustainable. [Paras 117, 118, 121, 122] The additional claim for weighted deduction under section 35(2AB) was directed to be allowed. Deduction on actual payment basis - Verification of payment under section 43B - additional claim for deduction of bonus under section 43B - HELD THAT: - The Tribunal held that allowability of the claim depended upon proof that the liability had actually been discharged within the prescribed time, which required examination of supporting records such as payment evidence, bank entries, ledger accounts and reconciliation with the computation. As the appellate authority had not allowed the claim for want of complete verification, the matter was restored for fresh factual examination. [Paras 126, 127, 128, 129] The issue was remanded to the Assessing Officer for verification of actual payment and fresh adjudication. Final Conclusion: The Revenue's appeal was dismissed in full. In the assessee's appeal, the claim for additional weighted deduction under section 35(2AB) was allowed, the disallowances relating to freebies and delayed employees' contribution were sustained, and the claim for deduction of bonus under section 43B was restored to the Assessing Officer for verification.
TaxTMI 
of 23710 
Get Daily Updates 
